Choosing - and sticking with - active surveillance: A patient's story
Choosing — and sticking with — active surveillance: A patient's story
In 1997, Jeffrey Caruso's physician recommended prostate-specific antigen (PSA) screening as part of Caruso's annual checkup. Then a 57-year-old businessman and avid bicyclist, Caruso* hadn't had any prostate problems, but he agreed that regular PSA screening was probably wise for someone his age. The result — 3.9 ng/ml — raised some concern because it fell at the upper end of what was considered the normal PSA range: 0 to 4.0 ng/ml.
*Editor's note: To protect his privacy, the patient's name and some biographical details have been changed. All medical details are as reported. In keeping with editorial policy, the patient's physicians are not named.